Abigail Perez Rodriguez, K. Tajima-Pozo, Adrian Lewczuk, F. Montañés-Rada
{"title":"非典型抗精神病药物和代谢综合征","authors":"Abigail Perez Rodriguez, K. Tajima-Pozo, Adrian Lewczuk, F. Montañés-Rada","doi":"10.1097/XCE.0000000000000063","DOIUrl":null,"url":null,"abstract":"Atypical antipsychotics have become the gold standard and the first treatment option for mental illness in recent years. However, despite all the benefits provided by these drugs, a growing collection of case reports and clinical trials describing metabolic complications and body weight gain have been reported. Among atypical antipsychotic drugs, olanzapine and clozapine appear to have the highest tendency to disturb glucose metabolism compared with the other antipsychotic drugs available on the market.","PeriodicalId":72529,"journal":{"name":"Cardiovascular endocrinology","volume":"24 1","pages":"132–137"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Atypical antipsychotics and metabolic syndrome\",\"authors\":\"Abigail Perez Rodriguez, K. Tajima-Pozo, Adrian Lewczuk, F. Montañés-Rada\",\"doi\":\"10.1097/XCE.0000000000000063\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Atypical antipsychotics have become the gold standard and the first treatment option for mental illness in recent years. However, despite all the benefits provided by these drugs, a growing collection of case reports and clinical trials describing metabolic complications and body weight gain have been reported. Among atypical antipsychotic drugs, olanzapine and clozapine appear to have the highest tendency to disturb glucose metabolism compared with the other antipsychotic drugs available on the market.\",\"PeriodicalId\":72529,\"journal\":{\"name\":\"Cardiovascular endocrinology\",\"volume\":\"24 1\",\"pages\":\"132–137\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/XCE.0000000000000063\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/XCE.0000000000000063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Atypical antipsychotics have become the gold standard and the first treatment option for mental illness in recent years. However, despite all the benefits provided by these drugs, a growing collection of case reports and clinical trials describing metabolic complications and body weight gain have been reported. Among atypical antipsychotic drugs, olanzapine and clozapine appear to have the highest tendency to disturb glucose metabolism compared with the other antipsychotic drugs available on the market.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
